Kenneth Gordon to Crohn Disease
This is a "connection" page, showing publications Kenneth Gordon has written about Crohn Disease.
Connection Strength
0.475
-
Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis. Adv Ther. 2020 01; 37(1):364-380.
Score: 0.452
-
Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease. Ann Rheum Dis. 2013 Apr; 72(4):517-24.
Score: 0.017
-
The cutaneous manifestations of gastrointestinal disease. Prim Care. 1996 Sep; 23(3):455-76.
Score: 0.006